English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Canada approves Phthorimaea operculella granulovirus isolate GV-0019 and Tutavirqrcode

May. 27, 2024

Favorites Print
Forward
May. 27, 2024

Health Canada’s Pest Management Regulatory Agency (PMRA), under the authority of the Pest Control Products Act, is granting registration for the sale and use of PhopGV Technical and Tutavir, containing the technical grade active ingredient Phthorimaea operculella granulovirus isolate GV-0019, for control of tomato leafminer (Tuta absoluta) on greenhouse fruiting vegetables.


Phthorimaea operculella granulovirus isolate GV-0019 is an insect-specific baculovirus and is the active ingredient in the insecticide product, Tutavir. Tutavir infects only larvae of certain Lepidopteran species (for example, moths) and acts only on ingestion by larvae, not by contact.


The Proposed Registration Decision PRD2024-01, Phthorimaea operculella granulovirus isolate GV‑0019 and Tutavir, containing the detailed evaluation of the information submitted in support of this registration, underwent a 45 day consultation period ending on 11 April 2024. The evaluation found that, under the approved conditions of use, the health and environmental risks and the value of the pest control product(s) are acceptable. Health Canada received no comments on PRD2024-01, Phthorimaea operculella granulovirus isolate GV‑0019 and Tutavir, during the public consultation period conducted in accordance with section 28 of the Pest Control Products Act.



BioEx2025-02_副本.jpg

6th Biopesticides, Biostimulants and Biofertilizers Summit (BioEx 2025)


BioEx 2025 is now in preparation, and you are welcome to consult and collaborate with us!

 Submit speech abstract  |  Become a sponsor  |  Become an exhibitor   Previous BioEx  


Contact: Christina Xie

Email: christina@agropages.com

Mobile (WeChat/WhatsApp): +86 18806513367


0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe BioEx Biweekly to send news related to your mailbox